Medifast (MED) Gross Profit (2010 - 2026)

Medifast has reported Gross Profit for 17 years, with the latest figure at $51.8 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit fell 38.56% year-over-year to $51.8 million; the trailing twelve-month figure through Mar 2026 stood at $242.7 million (down 39.56% YoY), and the FY2025 full-year result was $275.2 million, down 38.11% from the prior year.
• Gross Profit for Q1 2026 stood at $51.8 million, down from $52.1 million in the prior quarter.
• The five-year high for Gross Profit was $321.7 million in Q2 2022, with the low at $51.8 million in Q1 2026.
• Historically, Gross Profit has averaged $158.1 million across 5 years, with a median of $127.3 million in 2024.
• Annual changes were most pronounced in 2022 — Gross Profit advanced 21.62% — and 2024, when it plunged 48.34%.
• Medifast's Gross Profit stood at $233.6 million in 2022, then sank by 39.48% to $141.4 million in 2023, then plunged by 37.6% to $88.2 million in 2024, then sank by 40.9% to $52.1 million in 2025, then decreased by 0.74% to $51.8 million in 2026.
• The last three Gross Profit figures came in at $51.8 million (Q1 2026), $52.1 million (Q4 2025), and $62.2 million (Q3 2025), per Business Quant data.